• DSHS HIV/STD Program

    Post Office Box 149347, MC 1873
    Austin, Texas 78714

    Phone: (512) 533-3000

    E-mail the HIV/STD Program

    E-mail data requests to HIV/STD Program - This email can be used to request data and statistics on HIV, TB, and STDs in Texas. It cannot be used to get treatment or infection history for individuals, or to request information on programs and services. Please do not include any personal, identifying health information in your email such as HIV status, Date of Birth, Social Security Number, etc.

    For treatment/testing history, please contact your local Health Department.

    For information on HIV testing and services available to Persons Living with HIV and AIDS, please contact your local HIV services organization.

Pre-Exposure Prophylaxis (PrEP)

PrEP header

What is Prep?

Find a PrEP Provider in Texas Pre-exposure prophylaxis, or PrEP, is a way for HIV-negative people who are at very high risk to prevent getting an HIV infection by taking a pill every day. At present, the only FDA-approved medication for PrEP is oral tenofovir-emtricitabine (TDF-FTC), which is available as a fixed-dose combination in a tablet called Truvada®.

When someone is exposed to HIV through sex or injection drug use, these medicines can keep the virus from establishing a permanent infection. When taken consistently, PrEP reduces the risk of HIV infection by up to 92%.

DSHS and the U.S. Public Health Service recommend that PrEP be considered for people who are HIV-negative and at high risk for HIV.

PrEP: the Providers Role

For Texas, PrEP represents a focused opportunity to curb rising HIV infections in gay men and other men who have sex with men and among transgender women. PrEP can also prevent HIV infection among HIV-negative persons with an HIV-positive partner.

The extent to which PrEP can reduce the overall burden of HIV in Texas is highly dependent upon the willingness of health care providers to take the following four steps:

  1. Take a thorough sexual history from all patients as a part of routine medical care.

  2. Screen sexually active patients for HIV and other STDs based on sexual history and clinical guidelines.

  3. Talk about PrEP with HIV-negative patients at ongoing risk of exposure and HIV-positive patients who may have HIV-negative partners.

  4. Prescribe PrEP according to clinical guidelines, or refer patients to sites that provide PrEP.

PrEP Recommendations

Clinical Resources

Patient Resources

Contractor Resources

Last updated March 28, 2019